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CD83 Expression Influences CD4
T Cell Development in the Thymus
tional CD4CD8low thymocytes to become CD4or CD8
T cells (Lundberg et al., 1995; Robey et al., 1991; Suzuki
et al., 1995). CD4 coreceptor engagement contributes
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Department of Immunology strong signals that induce CD4 T cell generation, while
weaker CD8 coreceptor signals generate CD8 T cellsDuke University Medical Center
Durham, North Carolina 27710 (Basson et al., 1998; Bommhardt et al., 1997; Hernandez-
Hoyos et al., 2000; Matechak et al., 1996; Suzuki et al.,
1998; Yasutomo et al., 2000a). Additionally, an asymmet-
ric commitment model postulates that CD4 T cell differ-Summary
entiation occurs by default rather than by instruction
(Cibotti et al., 1997; Takahama et al., 1994). This com-T lymphocyte selection and lineage commitment in the
plexity undoubtedly reflects the myriad of molecular in-thymus requires multiple signals. Herein, CD4 T cell
teractions that influence thymocyte transcriptional regu-generation required engagement of CD83, a surface
lation and development.molecule expressed by thymic epithelial and dendritic
Regardless of stochastic or instructional lineage com-cells. CD83-deficient (CD83/) mice had a specific
mitment, accessory signaling steps are required for theblock in CD4 single-positive thymocyte development
maturation of DP thymocytes into CD4 or CD8 SPwithout increased CD4CD8 double- or CD8 single-
thymocytes (Brugnera et al., 2000; Sant’Angelo et al.,positive thymocytes. This resulted in a selective 75%–
1998). Although little is known about the signals and90% reduction in peripheral CD4 T cells, predomi-
cell surface molecules involved, transitional CD4CD8lownantly within the naive subset. Wild-type thymocytes
thymocytes require signals from thymic stromal cells toand bone marrow stem cells failed to differentiate into
become mature CD4 or CD8 T cells (Anderson et al.,mature CD4 T cells when transferred into CD83/
1996; Cibotti et al., 1997; Wilkinson et al., 1995). Amongmice, while CD83/ thymocytes and stem cells devel-
stromal cells, cortical epithelial cells provide the signalsoped normally in wild-type mice. Thereby, CD83 ex-
required for positive selection and lineage commitmentpression represents an additional regulatory compo-
(Laufer et al., 1996; Matzinger and Guerder, 1989). Rolesnent for CD4 T cell development in the thymus.
for dendritic cells (DCs) as antigen-presenting cells dur-
ing thymocyte selection and survival have also beenIntroduction
proposed, in addition to their roles in peripheral immune
responses (Ardavin, 1997; Steinman, 2000; Yasutomo et
The process by which immature thymocytes undergo
al., 2000b). Human dendritic lineage cells include thymic
lineage commitment and selection is the subject of in-
DCs, skin Langerhans cells, circulating DC, interdigitat-
tense investigation. Precursor cells enter the thymus as
ing reticulum cells present in the T cell zones of lymphoid
double-negative (DN, CD4CD8) thymocytes but
organs, and monocyte-derived DC, all of which express
upregulate expression of both CD4 and CD8 coreceptor
cell surface CD83 (Engel et al., 1995a; Kruse et al., 2000;
molecules to become CD4CD8 double-positive (DP)
Weissman et al., 1995; Zhou et al., 1992; Zhou and Ted-
thymocytes. DP thymocytes develop into mixed transi-
der, 1995a, 1995b). CD83 is primarily a marker for mature
tional CD4CD8low thymocytes before commitment to
DCs but is also expressed weakly by some germinal
either the CD4 or CD8 lineages as single positive (SP)
center lymphocytes and mitogen-activated lympho-
T cells (Lucas and Germain, 1996; Lundberg et al., 1995;
cytes (Zhou et al., 1992). Based on the pattern of CD83
Sant’Angelo et al., 1998; Suzuki et al., 1995). Immature
expression, its structural similarity with other members
DP thymocytes with a T cell antigen receptor (TCR) of
of the immunoglobulin superfamily (Kozlow et al., 1993;
high affinity for major histocompatibility complex (MHC)
Zhou et al., 1992), and the recent identification of poten-
molecules and self-peptide complexes are deleted (re-
tial ligands (Cramer et al., 2000; Lechmann et al., 2001;
ferred to as negative selection), while those with a TCR
Scholler et al., 2001), CD83 may serve important roles
of low affinity for self-peptide/MHC complexes are posi-
during intercellular interactions. Although CD83 does
tively selected and survive (Jameson and Bevan, 1998).
not share significant sequence homologies with other
Stochastic and instructional models explain how MHC
known proteins, human and mouse CD83 are well con-
specificity and coreceptor expression are linked during
served (63%) in amino acid sequence (Berchtold et
development (von Boehmer, 1994). The stochastic
al., 1999; Twist et al., 1998). Therefore, CD83-deficient
model proposes that CD4 or CD8 lineage commitment
(CD83/) mice were generated to understand its func-
occurs independent of TCR specificity, with either CD4
tion. Surprisingly, there was a specific block in thymo-
or CD8 expression terminated stochastically (Chan et
cyte development in CD83/ mice distinguished by a
al., 1993; van Meerwijk and Germain, 1993). In the in-
severe reduction in peripheral CD4 T cells.
structional model, quantitative signals induce transi-
Results
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Figure 1. CD83 Gene Disruption
(A) CD83 exons encoding untranslated (filled squares) and translated (open squares) regions.
(B) The gene-targeting vector contained thymidine kinase (tk) and neomycin resistance (neor ) genes.
(C) Gene targeting reduced a 17 kb EcoR I DNA cleavage product to 8.5 kb.
(D) Southern analysis of DNA from one targeted ES cell clone and littermate offspring from crosses of heterozygous CD83/ mice. Genomic
DNA was digested with EcoR I and hybridized with the DNA probe shown.
(E) CD83 expression by LPS-stimulated BM-DC generated from CD83/ and wild-type (CD83/) littermates. RNA was reverse transcribed
and PCR amplified using primers within the 5 and 3 untranslated regions (internal to the Hinc II site in exon 5), which generated a 660 bp
fragment when full-length CD83 transcripts were present. Actin was amplified as a control. Results in (D) and (E) represent three littermate
pairs.
tor replaced parts of exons 3–5 with a neomycin resis- littermates. Although DN and DP thymocyte numbers
were generally normal, CD83/ littermates had a 68%tance gene that introduced upstream stop codons
within CD83 transcripts (Figures 1A–1C). The deleted reduction in CD4 SP thymocyte numbers (Figure 2A).
The residual CD4 SP thymocytes in CD83/ mice wereDNA removes half the immunoglobulin-like domain (25
amino acids) of CD83 protein and the transmembrane predominantly CD8low (Figure 2A), with a CD69hi,
CD62Llow, CD24hi, and TCRint phenotype, indicating thatand cytoplasmic domains. Targeted CD83 gene disrup-
tion was confirmed by Southern blot analysis of genomic the CD4CD8low thymocytes were predominantly transi-
tional cells that had not committed to the CD4 lineage.DNA from ES cells and littermate offspring generated
from crosses of heterozygous CD83/ mice (Figure 1D). Overall, CD8 SP thymocytes did not increase in
CD83/ mice, although numbers varied slightly be-Bone marrow-derived dendritic cells (BM-DC) from
CD83/ mice failed to produce full-length CD83 tran- tween mice (Figure 2A). The phenotype of CD83/ mice
did not result from altered cell surface CD4 density,scripts, which were easily detected in wild-type BM-
DC (Figure 1E). CD83/ mice were produced at the since DP thymocytes and CD4 T cells expressed wild-
type levels of CD4 (Figures 2A and 2B). Therefore, CD83expected Mendelian frequency, thrived, and reproduced
as well as their wild-type littermates. Developmental or deficiency selectively inhibited CD4 thymocyte devel-
opment without a compensatory shift of DP thymocytesmorphological abnormalities were not obvious in
CD83/ mice up to 12 months of age. to the CD8 lineage.
CD83/ littermates had a profound 75%–90% reduc-
tion in peripheral CD4 T cells (Figure 2B), with a signifi-Impaired CD4 Thymocyte Development
in CD83/ Mice cant increase in the proportion of T cells with the charac-
teristics of memory cells (CD44high, CD45Rblow, andCD83/ mice had profound reductions in thymic and
peripheral CD4 T cells when compared with wild-type CD62Llow; Figure 2C, data not shown). The numbers of
CD83 Expression Regulates CD4 T Cell Development
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Figure 2. CD4 T Cell Deficiency in CD83/ Mice
(A) Immunofluorescence staining of thymocytes from CD83/ and wild-type littermates. The percentage of cells with CD4 SP, CD8 SP,
DN, or DP phenotypes are shown for each quadrant. Mean numbers of thymocytes in each subset are shown for six littermate pairs.
(B) Circulating lymphocytes from CD83/ and wild-type littermates.
Mean numbers of (C) T cells and (E) B220 B cells and within blood (cells/ml), spleen, and pooled inguinal, axial, and cervical lymph nodes
(LN) from 5–8 littermate pairs.
(D) TCR chain, CD3, and CD5 cell surface expression by circulating CD4 T cells as determined by three-color immunofluorescence analysis.
Each symbol represents one mouse. Asterisks indicate significantly different sample means between littermate pairs, p  0.05.
“naive” CD44lowCD4 T cells in blood, spleen, and lymph lymphoid tissues (Figure 2B). Peripheral B220 B cells
(Figure 2E), bone marrow leukocytes, peripheral mono-nodes of CD83/ littermates were reduced by 84%–
93% (Figure 2C). Both CD4 and CD8 T cells from cytes, neutrophils, and CD3CD16 NK cells developed
normally in CD83/mice. Therefore, CD83/mice wereCD83/ mice expressed wild-type levels of CD24 (HSA)
and CD69, suggesting that they were not systemically selectively defective in CD4 T cell generation due to
blocked CD4 SP thymocyte maturation.activated. However, TCR , CD3, and CD5 expression
were significantly lower on circulating CD4 T cells of
CD83/ mice (Figure 2D). TCR  chain expression was Impaired CD4 Thymocyte Development
in CD83/ AND Micealso lower on CD8 T cells of CD83/ mice, although
this difference was more prominent on CD4 T cells. To further clarify the role of CD83 in CD4 thymocyte
development, CD83/ mice were crossed with ANDCD8T cell numbers were increased in blood of CD83/
mice, although their numbers were normal in peripheral mice that carry MHC class II-specific TCR (V11, V3)
Cell
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Figure 3. CD4 T Cell Deficiency in CD83/ AND Mice
(A) Thymocyte subsets in representative CD83/ AND and AND littermates. Mean numbers from four littermate pairs are shown.
(B) V11 and CD4 expression by lymphocytes from pooled inguinal, axial, and cervical lymph nodes.
(C) Mean numbers of lymphocytes from four pairs of CD83/ AND and AND littermates. Asterisks indicate significantly different means
between littermate pairs, p  0.05.
transgenes, which positively select thymocyte develop- CD4 T Cell Development Requires CD83
Expression by Thymic Stromal Cellsment into the CD4 lineage when expressed in an H-2b
background (Kaye et al., 1989). Remarkably, very few Reflecting increased numbers of DP thymocytes and
decreased SP thymocyte numbers, thymi from CD83/CD4 SP thymocytes (5%) were found in CD83/ AND
littermates, with the majority being CD8low (Figure 3A). mice had a normal architecture with relatively large corti-
cal regions and correspondingly smaller medullary re-By contrast, 70% of thymocytes in AND mice were CD4
SP cells. Consistent with reduced CD4 thymocyte pro- gions. Differences in expression patterns of CD205, a
specific marker for thymic DC and cortical epithelialduction in CD83/ AND mice, CD4 T cell numbers
were reduced by 90% in the periphery (Figures 3B cells (Kraal et al., 1986), were not apparent (Figure 4A).
Numbers, morphology, and localization of CD205 DCsand 3C). DP and CD8 SP thymocyte numbers were
increased 5-fold and 4-fold, respectfully, in CD83/ in the thymic medulla, lymph nodes, and spleens of
CD83/ and wild-type littermates were also similarAND mice compared with AND transgenic littermates
(Figure 3A), suggesting that a small number of DP thy- (Figure 4A). In addition, thymic epithelial cells
(CD205CD11c) were isolated in equal numbers frommocytes were redirected to the CD8 lineage. Alterna-
tively, these CD8 AND cells may be differentiating in thymi of CD83/ and wild-type littermates. Remarkably,
in situ hybridization assays using CD83 antisense oligo-response to MHC class I recognition, since the TCR in
AND mice can direct MHC class I-dependent CD8T cell nucleotides demonstrated that cells throughout the cor-
tex expressed CD83 transcripts, with fewer CD83-maturation when CD4 expression is absent (Matechak
et al., 1996). This explanation is consistent with normal expressing cells in the medulla (Figure 4B). An antisense
CD83 probe did not hybridize with tissues in CD83/ miceCD8 T cell numbers in CD83/ mice (Figure 2) and
suggests that CD83 expression may promote CD4 sig- (Figure 4B). Sense probes did not hybridize in wild-type
and CD83/ mouse tissues. Purified thymic epithelialnals in DP thymocytes. Although circulating CD8 T cell
numbers were significantly increased in CD83/ AND cells (CD45CD205CD11c) and DC (CD205CD11c)
expressed CD83 transcripts at similar levels, while DPlittermates, CD8 T cell numbers within the spleen and
lymph nodes were normal. thymocytes did not express detectable CD83 transcripts
(Figure 4C). CD83 transcripts were expressed at 100-Impaired CD4 SP thymocyte and T cell development
in CD83/ mice were stable phenotypic characteristics. fold higher levels by BM-DC than total thymus tissue or
purified splenic T cells and B cells (Figure 4D). Thus,CD83/mice crossed with C57BL/6 mice for four gener-
ations maintained the striking phenotypic characteris- mouse CD83 was expressed by both thymic DC and
epithelial cells, in contrast to human thymus, where DCtics of CD83/ founder mice. This was also true for all
CD83/ AND littermates. Moreover, CD83/ geno- predominantly express CD83 (Zhou et al., 1992).
To assess whether CD83 on thymic DC or epithelialtypes and phenotypes remained 100% concordant, sug-
gesting that the phenotype of CD83/ mice resulted cells was required for CD4 T cell development, purified
thymic or splenic DCs or cultured fetal thymic epithelialfrom selective gene targeting rather than genetic alter-
ations independent of the CD83 locus. cells were transferred into the thymi of CD83/ mice.
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Figure 4. Epithelial and DC Expression of CD83
(A) Thymus sections from wild-type and CD83/ littermates stained for CD205. Cortical epithelial cells were stained most intensely (upper
right in images). Arrows indicate representative CD205 medullary DCs (magnification, 400).
(B) In situ hybridization of CD83 antisense oligonucleotide probe in thymus (40 and 400 magnification). Transcript-positive cells are stained
red with hematoxylin (blue) counterstain.
(C) CD83 expression by purified thymic DCs (CD205 CD11c), thymic epithelial cells (TEC; CD205 CD11), and DP thymocytes (Thy). Equal
amounts of RNA from each cell population was reverse transcribed, diluted in 10-fold increments, and PCR amplified using CD83-, keratin-,
or HPRT-specific primers.
(D) CD83 expression by cultured BM-DC, whole thymus, and purified splenic T and B cells. Lanes labeled 1, 1/10, 1/100, and 1/1000 represent
the PCR products from each dilution. (C) and (D) results represent those obtained using at least three littermate pairs of mice.
(E) CD4 SP thymocytes in thymic lobes of CD83/ mice injected with cultured thymic epithelial cells or purified thymic or splenic DC from
either wild-type or CD83/ donors. Each symbol represents results from individual thymic lobes.
(F) Phenotypes of BM-DC generated from CD83/ and wild-type littermates. Results represent at least three littermate pairs of mice.
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The injection of wild-type epithelial cells into CD83/ donors failed to develop into CD4 SP thymocytes in
CD83/ recipients by 1 and 3 weeks, but developed inmice increased CD4 SP T cell production by 2-fold,
while CD83/ epithelial cells did not alter CD4SP T cell normal proportions in wild-type littermates (Figure 5B,
Table 1). Peripheral V11 CD4 T cell numbers werenumbers (Figure 4E). By contrast, the transfer of wild-
type or CD83/ DCs into CD83/ mouse thymi did not equivalent when wild-type recipient mice were injected
with either CD83/ AND or AND thymocytes (Figure 5B,alter CD4 SP T cell production. While these results
do not rule out a role for DC CD83 in CD4 SP T cell Table 1). In addition, the peripheral V11 T cells in wild-
type recipients expressed V11, CD5, and CD3 at normaldevelopment, they demonstrate that epithelial cell CD83
contributes substantially to this process. Because of this, densities. Collectively, these results demonstrate that
thymocytes from CD83/ mice retain their potential tothymic epithelial cell and DC expression of costimulatory
molecules required for CD4 T cell development was as- develop normally in a CD83 microenvironment.
sessed. BM-DC from CD83/ mice expressed wild-type
levels of MHC class II (IA), CD80, CD86, and CD205 (Figure Impaired Hypersensitivity Responses
4F). Similarly, thymic DC (CD205CD11c) and epithelial and Humoral Immunity in CD83/ Mice
cells (CD205CD45CD11c) purified from CD83/ Contact hypersensitivity responses depend in part on
mice expressed wild-type levels of CD205 and near wild- the antigen-presenting capacity of Langerhans cells
type levels (80%–85%) of MHC class II, CD80, and within skin that induce antigen-specific CD4 T cells.
CD86. Human Langerhans cells express CD83 (Zhou et al.,
1992), and CD83 transcripts are found in mouse skin
(Twist et al., 1998). The ability of CD83/ mice to gener-CD83 Deficiency Does Not Affect Intrinsic
T Cell Development ate hypersensitivity responses was therefore assessed
by applying a hapten, oxazolone, to the skin with subse-Whether abnormal CD4 T cell development in CD83/
mice was due to intrinsic thymocyte defects or an al- quent ear lobe challenge. CD83-deficiency resulted in
a significant 22% reduction in swelling of oxazolone-tered thymic microenvironment was assessed in adop-
tive transfer experiments. Bone marrow cells from challenged ears compared with wild-type littermates
that was detected by 12 hr, peaked by 24 hr, and beganCD83/ AND and AND littermates were transplanted
into irradiated CD83/ and wild-type littermates. Four to subside by 48 hr (Figure 6A). Despite these differ-
ences, the ability of CD83/ DC to induce allogeneic Tweeks later, V11 thymocytes from both CD83/
AND and AND donors had developed normally into cell proliferation in vitro was normal. In mixed lympho-
cyte reaction (MLR) assays, BM-DC generated fromCD4 SP thymocytes in wild-type recipients (Figure 5A,
Table 1). By contrast, V11 thymocytes from either CD83/ and wild-type littermates induced allogeneic
T cell proliferation to the same extent (Figure 6B). InCD83/ AND or AND donors failed to develop into CD4
SP cells in CD83/ littermates. Moreover, there was a addition, CD4 T cells from CD83/ mice proliferated
normally in response to allogeneic BM-DC in MLRblockade of V11 thymocyte development at the DP
stage for bone marrow cells transplanted into CD83/ assays (Figure 6C). Both BM-DC and CD4 T cells from
CD83/ littermates were also normal in their ability tolittermates, resulting in a prominent accumulation of DP
V11 thymocytes relative to those present in wild-type stimulate or proliferate, respectively, during syngeneic
MLR assays. T cells from CD83/ mice also proliferatedrecipients (Table 1). These results did not reflect differ-
ences in the transplanted bone marrow cells, since simi- normally in response to stimulation with a mitogenic
anti-TCR or CD3 antibody, phytohemagglutinin (PHA)lar numbers of each thymocyte subset developed in
wild-type mice injected with either CD83/ AND or AND and Concanavalin A (Figures 6D and 6E). Therefore,
while peripheral DC or CD4 T cell function may bebone marrow cells (Table 1).
Peripheral V11 CD4 T cell numbers were equiva- impaired by CD83 deficiency, in vitro DC and T cell
function was normal in CD83/ mice.lent in wild-type recipients transplanted with either
CD83/ AND or AND bone marrow cells (Figure 5A, Reflecting a significant decrease in the number of
CD4 T cells exiting the thymus, the number of bromo-Table 1). In addition, the V11 T cells expressed V11,
CD5, and CD3 at wild-type densities. By contrast, V11 deoxyuridine (BrdU)-labeled cells among the CD44lowCD4
T cell subpopulation in blood, lymph nodes, and spleenCD4 T cell numbers were significantly reduced in
CD83/ recipients transplanted with either CD83/ was significantly lower in CD83/ mice than in wild-
type littermates following 10 or 30 days of BrdU labelingAND or AND bone marrow. A slight increase in the fre-
quency of CD8 SP thymocytes in CD83/ mice trans- (Figure 6F, data not shown). The number of BrdU-labeled
cells among the CD44highCD4 population was also re-planted with either CD83/ AND or AND bone marrow
cells (Table 1) was consistent with the phenotype of duced but was more similar to wild-type littermates (Fig-
ure 6F, data not shown). Consistent with this, CD83/CD83/ AND mice (Figure 3). However, peripheral
V11 CD8 T cell development was not significantly littermates had reduced humoral immune responses fol-
lowing challenge with a T cell-dependent antigen, 2,4-induced by transplanting CD83/ mice with either
CD83/ AND or AND bone marrow cells (Table 1). dinitrophenol-conjugated keyhole limpet hemocyanin
(DNP-KLH). Primary immune responses of all isotypesTo further confirm that impaired CD4 T cell develop-
ment in CD83/ mice was due to an intrinsic thymic were significantly reduced in CD83/ littermates (Figure
7A). Nonetheless, immune responses normalized follow-microenvironment defect, thymocytes from CD83/
AND and AND mice were directly transferred into the ing a secondary challenge (Figure 7A), and serum immu-
noglobulin levels were similar in CD83/ and wild-typethymi of irradiated CD83/ and wild-type littermates.
V11 thymocytes from both CD83/ AND and AND littermates (Figure 7B).
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Figure 5. CD83/ Thymocytes Develop Normally in Wild-Type Mice
(A) Bone marrow cells from CD83/ AND and AND littermates were transplanted into irradiated CD83/ and wild-type littermates.
(B) Thymocytes from CD83/ AND and AND littermates were transplanted into the thymus of irradiated CD83/ and wild-type littermates.
(A) Four and (B) three weeks later, the relative percentages of V11 cells expressing CD4 and/or CD8 were assessed in the thymus and
spleen. These results represent those shown in Table 1.
Decreased immune responses in CD83/ mice did immune responses but did not affect intrinsic B cell
proliferative function.not result from defective B cell maturation since IgM,
IgD, and CD19 expression were normal on splenic B
cells. Similarly, CD83/ B cells proliferated normally Discussion
following lipopolysaccharide (LPS) treatment and IgM
crosslinking in vitro (Figure 7C). However, splenic B cells These studies reveal a significant and unexpected role
for CD83 in CD4 T cell development. A profound reduc-from CD83/ mice expressed cell-surface MHC class
II antigens and CD86 at 50% and 20% lower levels tion in CD4 SP thymocyte development in CD83/
mice translated into a striking reduction in naive CD4than in wild-type littermates, respectively (Figure 7D).
Class II and CD86 expression by CD83/ B cells re- T cells in the periphery (Figure 2). Identical defects were
also found in CD83/ AND transgenic mice, a modelmained 3- to 4-fold below normal levels following activa-
tion with LPS, IL4, IgM, or interferon. Despite this, class system for examining positive selection (Figures 3A–3C).
Despite the dramatic effects of CD83 deficiency onII expression levels by blood and tissue monocytes from
CD83/ mice were wild-type. Therefore, CD83 defi- CD4 DP thymocyte development, CD8 T cell develop-
ment and numbers were generally normal (Figure 2).ciency significantly affected the activation status of pe-
ripheral B cells and inhibited antigen-specific humoral Blocked CD4 T cell development resulted from an in-
Cell
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Table 1. Normal CD83/ AND T Cell Development in Wild-Type Mice after Adoptive Transfer
Bone Marrow Transplantation Thymocyte Transfer
AND CD83/ AND AND CD83/ ANDDonor
Recipient Wild-Type CD83/ Wild-Type CD83/ Wild-Type CD83/ Wild-Type CD83/
Thymus (total number  106) Thymus (% of total)
CD4 SP 36 	 3 3 	 1** 39 	 4 3 	 1** 80 	 4 24 	 17** 82 	 3 39 	 3**
CD8 SP 0.5 	 0.1 1.4 	 0.2** 0.5 	 0.1 1.7 	 0.4** 4 	 1 11 	 8 5 	 1 27 	 1**
DP 18 	 2 51 	 9** 17 	 1 39 	 9** 12 	 3 63 	 26* 13 	 3 32 	 2**
Blood (cells/ml  103)
CD4 226 	 71 32 	 7** 387 	 82 18 	 13** 43 	 6 12 	 1** 54 	 16 5 	 2
CD8 23 	 4 27 	 5 28 	 6 13 	 4 4 	 1 4 	 1 5 	 1 2 	 1
Spleen ( 105)
CD4 68 	 9 27 	 6** 102 	 18 2 	 0.1** 1.9 	 0.3 1.6 	 0.1 2.2 	 0.8 1.0 	 0.6
CD8 4.0 	 0.1 0.7 	 0.2** 3.8 	 0.4 1.0 	 0.2** 0.1 0.2 0.1 0.1
ILN ( 103)
CD4 291 	 63 7 	 3** 270 	 88 2.4 	 1.0** 59 	 21 9 	 3 22 	 3 1.0**
CD8 15 	 4 6.2 	 2.2* 13 	 3 4.2 	 1.6 3 	 1 5 	 2 1.0 1.0
Results represent those obtained with at least four sets of mice of each phenotype. ILN refers to inguinal lymph node. Asterisks indicate
significantly different sample means between CD83/ and wild type littermates; single asterisk indicates p  0.05, double asterisk indicates
p  0.01.
trinsic defect in the thymic microenvironment, since 2C). The CD83/ phenotype was also distinct from that
of HD (helper T cell-deficient) mice with an intrinsic blockbone marrow stem cells and thymocytes from CD83/
mice developed normally into CD4 T cells when trans- in thymocyte development (Dave et al., 1998). In contrast
with CD83/ mice, CD4CD8low transitional thymocytesplanted into wild-type mice, but not CD83/ littermates
(Figure 5, Table 1). By contrast, wild-type thymocytes are markedly increased in HD mice, suggesting that
class II-restricted thymocytes are arrested at this stage.and bone marrow stem cells failed to differentiate into
CD4T cells when transplanted into CD83/ mice. Con- In addition, HD mice have normal numbers of peripheral
T cells, but they are all CD8. CD83-deficient mice hadsistent with this, CD83 was expressed by mouse thymic
DC and epithelial cells (Figure 4). In addition, wild-type near normal numbers of transitional thymocytes and
reduced peripheral T cell numbers, but no increase inepithelial cells transplanted into the thymi of CD83/
mice significantly increased CD4 SP T cell production, CD8 T cells. Therefore, the CD83/ phenotype is dis-
tinct from previously described mutations that affectwhile CD83/ epithelial cells did not (Figure 4E). CD83
deficiency did not affect the phenotypes, generation, thymocyte development.
In human thymus, CD83 is expressed predominantlyor distribution of thymic DC and epithelial cells in vivo
(Figure 4) or in vitro or affect the ability of DCs to stimu- by DC (Zhou et al., 1992). Comparable CD83 expression
patterns were predicted in mouse and human since theirlate T cell proliferation in MLR assays (Figure 6B). There-
fore, the lack of CD4 T cells in CD83/ mice primarily transcription regulatory sequences are similar (Mc-
Kinsey et al., 2000; Twist et al., 1998). As in humans,results from a deficiency in CD83 expression by non-
lymphoid cells within the thymus. Thus, CD83 deficiency CD83 transcripts were not detected in purified thymo-
cytes (Figure 4C) and were modest in spleen T andreveals an important but heretofore unrecognized devel-
opmental step in T cell maturation. B cells (Figure 4D). However, mouse thymic epithelial
cells expressed CD83, which was most obvious in theThe gross reductions in CD4 thymocytes and T cells
in CD83/ mice are characteristics reminiscent of CD4- thymic cortex (Figure 4B). Epithelial cell expression of
CD83 explains why the transplantation of wild-type boneand MHC class II-deficient mice (Cosgrove et al., 1991;
Grusby et al., 1991; Killeen et al., 1993; Rahemtulla et marrow stem cells into irradiated CD83/ mice did not
restore CD4 T cell generation, despite the introductional., 1991). However, CD4 expression was normal on DP
thymocytes and the few peripheral CD4 T cells found of CD83 DC (Figure 5A). This also explains why purified
thymic epithelial cells from wild-type mice increasedin CD83/ mice (Figures 2 and 3). Likewise, class II
antigen expression by CD83/ BM-DC, circulating and CD4 T cell production when transplanted into CD83/
mice (Figure 4E). Thus, epithelial cells are likely to betissue monocytes, thymic DC, and thymic epithelial cells
was near wild-type levels (Figure 4F), and reduced class the major source of CD83 expression in the thymus,
which is consistent with the rarity of thymic DCs (Ar-II expression in heterozygous class II-deficient mice
does not significantly affect CD4 T cell development davin, 1997; Zhou et al., 1992). Nonetheless, CD83 defi-
ciency did not affect the production of CD205 DCs in(Cosgrove et al., 1991; Grusby et al., 1991). Interrupting
CD4 and class II molecule interactions also results in thymus (Figure 4A), spleen, and lymph nodes or the in
vitro production and maturation of DCs (Figure 4F). It isincreased TCR and CD4 expression by DP thymocytes
(McCarthy et al., 1988; Nakayama et al., 1990), while therefore possible that a thymocyte receptor(s) for CD83
expressed by epithelial cells and/or DCs provides a pro-CD4 expression was normal in CD83/ mice (Figure
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Figure 6. Intrinsic DC and T Cell Function in CD83/ Mice
(A) Contact hypersensitivity in CD83/ and wild-type littermates. Values represent mean thickness of oxazolone- or carrier-challenged ear
lobes in six CD83/ and eight wild-type littermates. Significant differences between sample means are indicated; asterisks indicate p  0.05.
(B) Capacity of BM-DC from CD83/ and wild-type littermates to stimulate allogeneic CD4 T cells in MLR assays.
(C) Proliferative capacity of splenic CD4 T cells from CD83/ and wild-type littermates in response to allogeneic DC in MLR assays.
(D and E) Proliferation of splenic CD4 T cells from CD83/ and wild-type littermates in response to PHA and anti-TCR antibody.
(B–E) Values represent mean counts obtained from triplicate cultures and represent those obtained in four independent experiments.
(F) BrdU uptake by circulating naive and memory CD4 T cells. Each value represents the number of BrdU CD4 T cells per milliliter of blood
in individual mice after BrdU uptake over a 30 day period.
gression signal in addition to MHC interactions that reactions to oxazolone (Figure 6A) and antibody re-
sponses to a T cell-dependent antigen (Figure 7A) inallows T cells to enter or survive in the thymic medulla
and complete CD4 lineage development (Cibotti et al., CD83/ mice. Low MHC class II antigen expression by
resting B cells from CD83/ mice and reduced MHC1997; Iwata et al., 1996; Ohoka et al., 1996; Yasutomo
et al., 2000b). Since CD83 appears to provide a selective class II and CD86 induction following activation also
suggest additional requirements for CD83 expression inprogression signal for the CD4 but not to the CD8
lineage, these results reveal an additional step in CD4 B cell activation. These findings are concordant with
significant roles for DC in thymic and peripheral T celllineage development.
Decreased CD4 T cells in CD83/ mice did not result homeostasis (Brocker, 1997; Steinman, 2000). Consis-
tent with this, peripheral CD4 T cell numbers werefrom intrinsic T cell defects. Bone marrow stem cells
and thymocytes of CD83/ mice developed normally lower when CD83/ mice were transplanted with bone
marrow from CD83/ donors rather than wild-type lit-when transplanted into wild-type littermates (Figure 5,
Table 1). Moreover, CD4 T cells from CD83/ mice termates (Table 1). Nonetheless, CD83/ and wild-type
DCs generated equivalent levels of T cell proliferationproliferated normally in response to mitogens and during
MLR assays (Figures 6C–6E). Nonetheless, peripheral in allogeneic and syngeneic MLR assays (Figure 6B),
and serum immunoglobulin levels were normal inCD4 and CD8 T cells in CD83/ mice expressed TCR,
CD3, and CD5 at low levels (Figure 2D). In fact, CD4 CD83/ mice (Figure 7B). Thus, CD83 expression by
peripheral DC may support interactions between DCsSP thymocytes and peripheral CD4 T cells from
CD83/ mice expressed TCR at levels characteristic and naive T cells in the periphery and thereby influence
lymphocyte maturation, function, and turnover.of CD4CD8low thymocytes (Lucas and Germain, 1996;
Suzuki et al., 1995). This may explain decreased allergic In conclusion, CD83/ mice revealed a requirement
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for CD83 expression in CD4 T cell development and an
additional regulatory step during the complex network
of molecular interactions that controls thymocyte and
peripheral T cell generation. Whether defective CD4 T
cell development in CD83/ mice is due to defective
lineage commitment or aborted positive selection is un-
known. It remains possible that CD83 deficiency re-
duces TCR signaling during DP thymocyte selection,
although CD83 deficiency did not enhance differentia-
tion toward the CD8 lineage. Reduced TCR complex
signaling in CD83/ mice could result from lower avidity
interactions between the TCR and its accessory mole-
cules with MHC and other ligands or to reduced levels
of cytoplasmic signaling. Identification of the thymocyte
ligand(s) for CD83 will help untangle these possibilities.
Nonetheless, the accumulation of DP cells in CD83/
AND mice (Figure 3A) and the normal numbers of CD8
cells in CD83/ and CD83/ AND mice (Figures 2 and
3) suggest that early events in positive selection are not
disrupted. Since DCs and CD4 helper T cells are central
to the immune system and the generation of immune
responses, it is understandable that CD4 T cell homeo-
stasis is precisely controlled. In fact, reduced CD4 T
cell numbers is the major factor determining morbidity
and mortality in AIDS patients. While CD83 deficiency
may abrogate normal CD4 T cell development, it is
possible that augmenting CD83 expression or the en-
gagement of CD83 receptors on developing thymocytes
will provide signals that enhance CD4T cell production.
Thus, CD83-deficient mice may provide insight into the
development of new therapies to manipulate the devel-
opment of helper T lymphocytes in vivo.
Experimental Procedures
Generation of CD83/ Mice
DNA encoding CD83 was isolated from a 129/Sv strain genomic
library (Twist et al., 1998). The targeting vector 5 end contained the
pMC1-HSVTK gene ligated to a 1.1 kb DNA fragment that ended at
the Ava I site in CD83 exon 3 (Figure 1A). The region between the
Ava I restriction site located in CD83 exon 3 and the Hinc II site
located in the 3 untranslated region of exon 5 was replaced with
the PGK neomycin resistance gene in the 3 to 5 orientation. The
3 end of the targeting vector used a 6.3 kb DNA fragment that
started at the Hinc II site in the 3 untranslated region of the CD83
gene. The vector was linearized using a unique Xho I site in the
genomic DNA and electroporated into AK-7 ES cells (Selfridge et
al., 1992). Four gene-targeted ES cell clones were injected into 3.5-
day-old C57BL/6 blastocysts before transfer into foster mothers.
One ES cell clone provided germline transmission of the disrupted
allele. CD83/ offspring were backcrossed with C57BL/6 mice (The
Jackson Laboratory) and AND mice (provided by S.M. Hedrick, U.
California-San Diego) with genotypes determined by Southern blot
analysis of tail DNA. Heterozygous mice were intercrossed to gener-
ate homozygous CD83/ mice and wild-type littermate controls.
Mice were housed in a specific pathogen-free barrier facility and
used at 2 months of age. All procedures were approved by the Duke
Figure 7. B Cell Function in CD83/ Mice Animal Care and Use Committee.
(A) Humoral immune responses of CD83/ and wild-type littermates
Generation of BM-DCafter immunization with a T cell-dependent antigen. Six mice in each
BM-DCs were generated as described (Inaba et al., 1992). Briefly,group were immunized on day 0 and boosted on day 21. Significant
bone marrow cells (1  106/ml) from 6- to 8-week-old mice weredifferences are indicated; asterisks indicate p  0.05.
(B) Serum immunoglobulin levels in CD83/ and wild-type lit-
termates. Symbols represent results from individual mice as deter-
mined by ELISA. (D) MHC class II antigen and CD86 expression by resting and LPS-
(C) Proliferation of splenic B cells in response to LPS and anti-IgM stimulated splenic B cells after 24 hr. Values represent the mean
antibody. Values represent mean counts obtained from triplicate fluorescence intensity of antigen expression as determined by flow
cultures and represent those obtained in four independent experi- cytometry analysis of cells from three CD83/ and wild-type lit-
ments. termates.
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cultured at 37
C in 6-well Falcon culture plates containing enriched littermates. Ten days later, thymocytes were isolated from each lobe
for analysis.RPMI 1640 culture medium supplemented with mouse GM-CSF (200
U/ml; PharMingen). On days 3 and 5 of culture, nonadherent cells
were gently removed by rinsing, and fresh medium and GM-CSF Lymphocyte Function Assays
were added. On day 7, the nonadherent cells were collected by CD4 T cells and B220 B cells were isolated (95% purity) from
gentle pipetting, resuspended in 10 ml of culture medium containing single-cell spleen suspensions using antibody-coated magnetic
GM-CSF, and transferred to 100 mm tissue culture dishes. DCs were beads (Dynal). For MLR assays, CD4 T cells (4  105) were mixed
collected for use in MLR assays on day 9, while DCs for phenotypic with BM-DC from syngeneic or allogeneic (BALB/c) mice and cul-
analysis or RNA preparation were cultured until day 11. tured for 5 days. For mitogen assays, CD4 T cells were cultured
with anti-mouse TCR or CD3 antibody (PharMingen), PHA (Sigma)
or Concanavalin A (Sigma), while B cells were stimulated with LPSReverse Transcription-Polymerase Chain Reaction
(E. coli serotype 0111;B4, Sigma) or anti-IgM antibody (Cappel) for(PCR) Assays
3 days. Proliferation during the last 18 hr of culture was assessedDP thymocytes, thymic DC (CD205 CD11c), and cortical thymic
by [3H]thymidine incorporation. For contact hypersensitivity assays,epithelial cells (CD205 CD11) were purified from single-cell sus-
mice were sensitized on the flank with oxazolone (Sigma) and chal-pensions of collagenase-treated thymi by fluorescence-based cell
lenged on one ear 5 days later (Tedder et al., 1995). Carrier wassorting. RNA was reverse transcribed and PCR amplified using a
administered to the other ear as a control. Each day after challenge,sense primer representing 5 untranslated sequence (TGT CGC AGC
the thickness of the central portion of ear lobes was measured threeGCT CCA GCC) and antisense primer representing 3 untranslated
times using a constant force, digital thickness gauge with meanssequence (GCA TTC AGG CAC ACT GAT C). Keratin 5 was amplified
used for analysis.as a marker for thymic epithelial cells. Primers specific for actin
Mice were immunized i.p. with 100 g of DNP-KLH (Calbiochem-and HPRT transcripts were used to verify the efficiency of cDNA
Novabiochem) in complete Freund’s adjuvant and were boosted 21synthesis and PCR amplification.
days later as described (Engel et al., 1995b). Serum antibody levels
and DNP-specific antibody titers were measured as described (En-
Immunofluorescence Analysis, In Situ Hybridization, gel et al., 1995b).
and BrdU Labeling
Single-cell suspensions were stained with biotin- or fluorochrome- Statistical Analysis
conjugated antibodies (from PharMingen, Caltag, or Southern Bio- All data are shown as mean values 	 SEM. The Student’s t test
technology Associates) as described (Engel et al., 1995b). Biotin- statistic was used to determine the level of significance of differ-
conjugated antibodies were revealed by fluorochrome-conjugated ences in sample means.
streptavidin. Labeled cells were analyzed on a FACScan flow cytom-
eter (Becton Dickinson). Acknowledgments
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Mice were provided with drinking water containing BrdU (0.8 mg/
ml, Sigma). The frequency of BrdU cells within the blood and tis-
Referencessues was determined 10–30 days later using FITC-labeled anti-BrdU
antibody (Becton Dickinson) as described (Tough and Sprent, 1994).
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